A proposed update to the requirements for training pediatricians is prompting concerns that future doctors may be less prepared to treat children with developmental disabilities.
In its May 25, 2021 issue, JAMA published a report on the comparative efficacy of two medications for treating preschoolers diagnosed with ADHD. Both methy
May 11, 2021
Alpha-2 adrenergic agonists may effectively treat ADHD in preschoolers with fewer side effects than first-line stimulant medications, according to a new study published in the
Journal of the American Medical Association that claims to be the first to compare the two classes of ADHD medication in preschool-aged children
.
1
The health records of nearly 500 children (primarily males) revealed that 78% of children treated with stimulants showed an improvement in ADHD symptoms, while 66% of preschoolers who took an alpha agonist (like guanfacine) showed improved symptoms. However, participants taking the latter reported fewer side effects namely, lower rates of moodiness/irritability, appetite loss, and difficulty sleeping. Dr. Tanya Froehlich, professor and research director at Cincinnati Children’s Hospital Medical Center, explained: “For young children with ADHD who haven’t had enough improvement with behavioral therapy, both methylphenidate and guanfacin